MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Mixed Reality Multimodal System for Objective Assessment of Motor and Cognitive Functions in Neurodegenerative Diseases

D. Hemmerling, J. Stepien, W. Szecowka, A. Channarayapatna Srinivasa, M. Rudzińska-Bar, M. Wojcik-Pedziwiatr, . (Krakow, Poland)

Meeting: 2025 International Congress

Keywords: Dystonic tremor, Gait disorders: Clinical features, Parkinson’s

Category: Telemedicine

Objective: This study aimed to develop an immersive system using Microsoft HoloLens 2 for assessing motor and cognitive functions by integrating speech, movement, and eye-tracking analyses in neurodegenerative disease patients.

Background: Parkinson’s disease is a neurodegenerative disorder with symptoms such as tremors, bradykinesia, rigidity, postural instability, and speech impairments. MR technology allows convenient at-home data collection, minimizing stress. Combined with AI analysis, it creates an automated diagnostic system.

Method: Current assessments rely on subjective scales. MR and multimodal integration offer more precise evaluations. Our system combines speech, gait, hand movement, and eye-tracking analyses. The protocol includes 18 tasks guided by an MR application, lasting 27 minutes. 50 patients and 50 healthy controls participated. Clinical assessments included MDS-UPDRS, VHI, Tinetti Test, MMSE, and BDI. The system extracts 500+ parameters, such as speech (F0, jitter, shimmer), gait (step length variability), hand motion (3D tracking), and eye movement (saccade latency).

Results: Analysis showed significant differences in PQ sensor fidelity (p = 0.048) and SUS scores (p = 0.005), with large effect sizes (Cohen’s d = 1.16 and 0.78).  The system successfully extracted multimodal parameters. MR assessments improved engagement and data quality. SUS scores confirmed high usability, with task performance correlating with clinical scales like MDS-UPDRS3, Timed Up and Go Test, and VHI.

Conclusion: This automated system enables detailed symptom assessment without physician supervision. MR enhances engagement and data precision, providing a valuable tool for clinical and research applications. The project was funded by The National Centre for Research and Development, Poland under Lider Grant no: LIDER/6/0049/L-12/20/NCBIR/2021 and by the Ministry of Science and Higher Education (MNiSW) under the project no. MNiSW/2025/DPI/53, Support for Students in Enhancing Their Competencies and Skills.

To cite this abstract in AMA style:

D. Hemmerling, J. Stepien, W. Szecowka, A. Channarayapatna Srinivasa, M. Rudzińska-Bar, M. Wojcik-Pedziwiatr, . . A Mixed Reality Multimodal System for Objective Assessment of Motor and Cognitive Functions in Neurodegenerative Diseases [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/a-mixed-reality-multimodal-system-for-objective-assessment-of-motor-and-cognitive-functions-in-neurodegenerative-diseases/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-mixed-reality-multimodal-system-for-objective-assessment-of-motor-and-cognitive-functions-in-neurodegenerative-diseases/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley